Rao et al. 10.1073/pnas.0712328105.

Supporting Information

Files in this Data Supplement:

SI Figure 7
SI Figure 8
SI Figure 9
SI Table 1
SI Figure 10
SI Figure 11
SI Table 2
SI Text




SI Figure 7

Fig. 7. Targeted disruption of the Organic Solute Transporter alpha subunit gene (Osta). (A) Schematic representation of the wild-type Osta gene (Wild type Osta allele) showing the locations of exons 1 to 9 and the SacI restriction enzyme cleavage sites used to construct the conventional targeting vector. The murine Osta gene is organized in 9 exons spanning »13-kb of DNA sequence. The first exon encompasses the 5' untranslated region and encodes amino acids 1 to 13. Exons 2 through 9 include the remaining coding sequence (amino acids 14 to 340). Exon 9 also encodes a 3' untranslated region of 205 nucleotides. Exons 1, 2, and the proximal promoter region are replaced by the neomycin resistance gene (neo) as a result of homologous recombination (Targeted Osta allele), such that the neomycin gene is transcribed in the opposite direction of the Osta gene. After deletion of these coding exons, the next potential in-frame methionine lies in exon 3 at position 117. In the event that an aberrant Osta transcript is generated from the targeted locus, the primary translation product would be a mutant protein lacking the first 116 aa, including the extracellular amino terminus and the first 2 potential transmembrane domains. (B) Southern blot analysis of HindIII-BamHI (left panel) or HindIII-SspI (Right) digested genomic DNA from wild-type embryonic stem cells (WT) or the embryonic stem cell clone (2C3) that was injected into blastocysts to produce the Osta-/-mice. The blots were hybridized with a [a-32P]dCTP-labeled 361 bp StuI-XbaI fragment (Probe A) derived from Osta 5' flanking sequence immediately upstream of the short arm. (C) Genotype analysis of mice with different Osta alleles. Schematic representation of the wild-type and targeted Osta gene showing the locations of allele-specific PCR primers used for genotype analysis. Genomic DNA was isolated from animals of the indicated genotype and PCR amplified using the indicated primers as described in Materials and Methods. The products were resolved on a 1% agarose gel and their sizes are indicated.





SI Figure 8

Fig. 8. Expression of Osta-Ostbm RNA and protein in Osta-/-mice. (A) Northern blot analysis of Osta and Ostb mRNA in wild-type and Osta-/-mice. The small intestines were isolated from wild-type and Osta-/-male mice (n = 5 mice per genotype; 3 months of age; mixed C57BL/6J-129/SvEv background), divided into five segments of equal length, and used to isolate RNA. Pooled aliquots of total RNA (10 mg) were subjected to Northern blot hybridization using radiolabeled full-length cDNA probes for mouse Osta, Ostb, and b-actin. No Osta mRNA was detectable in small intestine from the Osta-/-mice, indicating that replacement of the 5' region of the Osta gene with the neomycin resistance cassette region abolished transcription of the Osta gene or generated an unstable transcript that is rapidly degraded. In contrast, Ostb mRNA remained highly expressed in small intestine of the Osta-/-mice. (B) Ileal expression of Ostaand Ostb protein in wild-type and Osta-/-mice. The small intestines were isolated from male and female mice of the indicated genotypes (n = 2 mice per group, 4 months of age; mixed C57BL/6J-129/SvEv background), divided into five segments of equal length, and terminal ileum (segment 5) was used to prepare tissue protein extracts. Equivalent amounts (50 mg) of ileal protein extract from the indicated genotypes were resolved by SDS/PAGE, transferred to nitrocellulose, and probed with anti-Osta or anti-Ostb antibody. The blots were then reprobed using an anti-b-actin antibody as a control for protein loading.





SI Figure 9

Fig. 9. Body weights of wild-type, Osta+/-, and Osta -/-mice. Mean values ± SE are shown. (A) Males (n = 7-18 mice per genotype). (B) Females (n = 7-15 mice per genotype). An asterisk indicates body weights of Osta-/-mice that are significantly different from wild type and heterozygous mice (*P < 0.05).





Table 1. Pooled serum samples (n = 5 mice per gender and genotype; 3 months of age

Parameter

Ostα

+/+

Ostα

-/-

Ostα

+/+

Ostα

-/-

 

Males

 

Females

 

General

 

 

 

 

Weight (g)

28.8 ± 1.5

26.6 ± 0.7

21.4 ± 0.7

21.4 ± 0.7

Glucose (mg/dl)

334

332

246

275

Urea Nitrogen (mg/dl)

22

26

20

27

Creatinine (mg/dl)

0.1

0.1

0.4

0.1

Total protein (g/dl)

3.9

3.8

4.5

3.9

Total Bilirubin (g/dl)

0.1

0.1

0.1

0.1

Calcium (mg/dl)

1.3

1.3

4.0

1.1

Phosphorus (mg/dl)

6.3

6.6

7.9

7.0

Cholesterol (mg/dl)a

61 ± 7

66 ± 2

51 ± 6

36 ± 4*

Triglycerides (mg/dl)a

62 ± 5

55 ± 8

51 ± 10

38 ± 6*

Serum Enzymes

 

 

 

 

Alkaline Phosphatase (unit/liter)

26

36

151

46

ALT/SGPT (unit/liter)

24

51

21

18

a

, serum samples from individual mice were analyzed (n = 5 mice per gender and genotype), means + SE, *, P < 0.05 vs. gender-matched wild-type mice.



SI Figure 10

Fig. 10. Taurocholate transport in everted gut sacs. (A) Small intestines from Osta+/+ male mice were divided into four equal parts, everted, and used to prepare gut sacs. The individual everted sacs were incubated for 30 min at 37°C in oxygenated KRB containing 25 mM [3H]taurocholate and inulin [14C]carboxylic acid (as a control for leakage and paracellular movement). Mean values ± SE are shown (n = 3-5 mice per segment). Taurocholate transport was largely restricted to the distal portion (ileum) of the small intestine. (B) Taurocholate content of tissue extracts prepared from jejunal and ileal gut sacs. After rinsing the sacs and removing the serosal fluid, the gut sacs were solubilized and used to determine the amount of tissue-associated taurocholate. Mean values ± SE are shown (males, n = 3-6 mice per segment; females, n = 3-7 mice per segment). Different letters represent significant differences between groups (P < 0.05 by Tukey's honestly significant difference test). The tissue-associated taurocholate was significantly lower in sacs prepared from the Osta-/-mice versus wild-type mice (Males and Females). (C) Efflux of taurocholate from the tissue to the serosal side. The amount of taurocholate measured in serosal fluid (Fig. 2) was divided by the amount of taurocholate associated with the tissue (Fig. 10B).





SI Figure 11

Fig. 11. Fecal bile acid excretion in wild-type and Osta-/-mice. Fecal bile acid excretion was measured in mice at 1 month of age as described in Materials and Methods. Mean ± SE are shown (n = 10 mice per group). At 1 month of age, fecal bile acid excretion levels were similar in the wild-type and Osta-/-mice.





Table 2. Primer sequences

Cyclophilin

5'-TGGAGAGCACCAAGACAGACA-3'

 

5'-TGCCGGAGTCGACAATGAT-3'

FGF15

5'-GAGGACCAAAACGAACGAAATT-3'

 

5'-ACGTCCTTGATGGCAATCG-3'

Cyp7a1

5'-AGCAACTAAACAACCTGCCAGTACTA-3'

 

5'-GTCCGGATATTCAAGGATGCA-3'

Cyp8b1

5'-GCCTTCAAGTATGATCGGTTCCT-3'

 

5'-GATCTTCTTGCCCGACTTGTAGA-3'

Ostα

5'-TACAAGAACACCCTTTGCCC-3'

 

5'-CGAGGAATCCAGAGACCAAA -3'

Ostβ

5'-GTATTTTCGTGCAGAAGATGCG-3'

 

5'-TTTCTGTTTGCCAGGATGCTC-3'

Asbt

5'-TGGGTTTCTTCCTGGCTAGACT-3'

 

5'-TGTTCTGCATTCCAGTTTCCAA-3'

Ibabp

5'-CAAGGCTACCGTGAAGATGGA-3'

 

5'-CCCACGACCTCCGAAGTCT-3'

SHP

5'-CAGCGCTGCCTGGAGTCT-3'

 

5'-AGGATCGTGCCCTTCAGGTA -3'

Mrp3

5'-AGAGCTGGGCTCCAAGTTCT-3'

 

5'-TGGTGTCTCAGGTAAAACAGGTAGCA-3'





SI Text

Expanded Materials and Methods Animal Experiments.

Mice were housed in our American Association for the Accreditation of Laboratory Animal Care-approved animal facility; the Institutional Animal Care and Use Committee approved all animal procedures. Mice were group-housed in plastic colony cages in a temperature-controlled room (22°C) with 12-h light cycling, and fed ad libitum standard rodent chow or a prepared basal diet (1) containing 0.2% cholic acid. The pups were weaned at 26 days and all experiments were performed using age-and gender-matched mice. Unless indicated, the mice were fasted for »4 h (from 8 a.m. to 12 p.m.) and then killed for the experiments in this study. Serum chemistry parameters were determined at Antech Diagnostics. Plasma total cholesterol (Wako) and triglyceride (Roche Applied Science) were determined by enzymatic assay (2).

Generation of Osta-/-and Osta-/-Mrp3-/- Mice.

Oligonucleotide primers based on the mouse Osta cDNA sequence were used to screen a mouse (strain 129S6/SvEvTac) PAC library (ResGen RPCI-21; Invitrogen). Three clones were identified and mapped using Southern blot and PCR analysis. The targeting vector was constructed using the PAC genomic DNA clones as a source of mouse Osta sequence. For the short arm of the targeting vector, a 0.9-kb fragment encompassing the proximal promoter (nucleotides -1569 to -673 relative to the putative cap site that is located 357 nucleotides upstream of the initiator methionine) was PCR amplified from the PAC clone and subcloned into a pGEM T-easy vector (Promega). A 7.5-kb SacI fragment extending from the second to the third intron was used for the long arm of the targeting vector. The murine Osta short and long arm DNA fragments were ligated sequentially into the EcoRI and SacI sites, respectively, of the PNT plasmid (3) such that the neomycin resistance gene (neo) is transcribed in the opposite orientation of the Osta gene (Fig. 7A). The orientation and junctions of the DNA fragments were confirmed by DNA sequencing. The targeting vector was linearized by cleavage with NotI and introduced by electroporation into mouse embryonic stem cells as described (4). Isolation of the targeted embryonic stem cells and blastocyst injections were performed in the Transgenic Mouse Core Facility of Wake Forest University Health Sciences. Briefly, 129S6/SvEv mouse-derived embryonic stem cells (SM-1, Passage 11) were cultured on irradiated (10,000 rad) STO feeder cells. »2 ´ 107 embryonic stem cells were electroporated with 100 mg of NotI-linearized targeting construct (330 mF, 275 V, low resistance) using an Invitrogen Cell-Porator. The cells were then seeded onto STO feeder layers for 24 h and selected for 8-10 days in media containing 250 mg/ml G418 and 2 mM ganciclovir (Syntex). Two positive clones were identified by PCR amplification (targeting efficiency ~1%) and verified by sequencing and Southern blot analysis (Fig. 7B). Clone 2C3 was expanded and injected into 3.5-day-old C57BL/6J blastocysts. Surviving blastocysts were transferred to the uteri of pseudopregnant foster CD-1 females. This produced 12 high-percentage male chimera progeny that were crossed with female C57BL/6J mice (The Jackson Laboratory) to ultimately transmit the mutation through the germline; the offspring were genotyped by PCR using primer pairs specific for the wild type (5'-CACACACGGTCACTTTGCTC-3'; 5'-GCTTCTGGAACTTCTGGAGAC-3') or mutant Ostaalleles (5'-CACACACGGTCACTTTGCTC-3'; 5'-CCAGTCATAGCCGAATAGCC-3') (Fig. 7C). For analysis of Osta-/-mice, experiments were performed with mixed strain (C57BL/6J-129S6/SvEv) descendants (F2 and subsequent generations) using Osta+/+ littermates as controls. The Mrp3-/-mice are on a C57BL6/J background and have been described previously (5). Osta -/-Mrp3-/-mice were generated by crossbreeding the corresponding null mice. The Osta-/-Mrp3-/-mice are on a mixed background (C57BL/6J-129/SvEv) and were compared with Osta+/+Mrp3-/-or Osta+/+Mrp3+/+ littermates as controls. The Asbt-/-mice used in this study are on a mixed 129/SvEv-C57BL6/J (1) or C57BL/6J background (generated by backcrossing for eightgenerations) as indicated.

RNA and Protein Analyses.

Total RNA was extracted from frozen tissue using TRIzol Reagent (Invitrogen) as suggested by the manufacturer. Northern blot and real time PCR analysis of Osta and Ostb expression was performed as described previously (6, 7). The primer sequences for the real time PCR analysis are provided in Table 2. Tissue extracts were prepared as described (7) and subjected to immunoblotting analysis using an affinity-purified rabbit anti-peptide antibody raised to amino acids 315-329 of mouse Osta and a rabbit anti-glutathione S-transferase fusion protein antibody (whole serum or an ammonium sulfate-isolated Ig fraction) raised against amino acids 54 to 128 of mouse Ostb (6, 7). The following dilutions of antibodies were used: anti-Osta and anti-Ostb, 1:1000; anti-b-actin, 1:10,000; HRP-conjugated anti-rabbit antibody (GE Healthcare), 1:5,000; HRP-conjugated anti-mouse antibody (GE Healthcare), 1:10,000. Antibody binding was detected using an enhanced chemiluminescence technique (SuperSignal West Pico; Pierce). The blots were also probed with mouse anti-b-actin antibody (Sigma; catalog number A5441) as a control for protein loading. Ostb protein expression was quantified by scanning multiple exposures of the x-ray films using an Alpha Innotec 5500 imaging system and protein loading was normalized for the expression b-actin.

Everted Gut Sac Transport Measurements.

Male and female mice from 3 to 7 months of age were used to prepare gut sacs. The mice were anesthetized with ketamine-xylazine, killed, and the small intestine was quickly removed and divided into 4 equal segments. Each segment was rinsed with cold PBS and the adhering fat was removed. A 7 cm segment from the center of each segment was weighed and gently everted over an 18-ga Hamilton needle. One end of the everted segment was ligated using 4-0 polyglactin suture (Ethicon), and the sac was filled with 150 to 500 ml of Krebs Ringer Buffer (KRB) (118 mM NaCl, 4.75 mM KCl, 2.5 mM CaCl2, 1.19 mM KH2PO4, 1.19 mM MgSO4, 25 mM NaHCO3, 11.1 mM glucose, pH 7.4). After closing the sac using 4-0 polyglactin suture, the sacs were weighed and incubated in a 15 ml Falcon tube containing KRB plus 25 mM sodium [3H]taurocholate (final specific activity = 55 mCi/mmol) (Perkin-Elmer) and 180,000 dpm/ml of inulin [14C]carboxylic acid (2 mCi/mmol; Amersham Pharmacia Biosciences) (as a marker for integrity of the gut sac and for paracellular movement). A concentration of 25 mM taurocholate was selected since this is approximately the Km for taurocholate transport by the mouse Asbt (8). The mucosal fluid was continuously gassed with 02/CO2 (95/5) and sacs were incubated for 30 min at 37°C in a shaking water bath. At the end of the incubation period, the sacs were removed, rinsed in cold KRB, weighed, and the serosal fluid was recovered. The empty sac was weighed and solubilized by incubation in 1 N NaOH for 150 min at 37°C. Aliquots of mucosal fluid, serosal fluid, and tissue extract were taken to determine the amount of radioactivity. The amount of inulin [14C]carboxylic acid associated with the sac or in the serosal fluid at the end of the 30 min incubation was similar for the different genders and genotypes; the inulin [14C]carboxylic acid was used to correct the sac-associated [3H]taurocholate measurements for adherent fluid and to correct the serosal fluid [3H]taurocholate measurements for leakage and paracellular movement.

Fecal Bile Acid and Neutral Sterol Excretion, Bile Acid Pool Size and Composition.

Mice were individually housed in wire bottom cages and stools collected for 3 days. Stools were dried, weighed, and ground. An aliquot of this material was extracted as described (9) and used to determine the total bile acid content by an enzymatic method (10). Recoveries were normalized to [14C]cholic acid (Perkin-Elmer Life Sciences) added to the dried feces. A second 0.1-g aliquot of dried stool was subjected to alkaline hydrolysis at 60°C for 1 h and neutral sterols were extracted into hexane. Neutral sterol content was then determined by gas-liquid chromatography using a DB 17 column (J. & W. Scientific) installed in a Hewlett-Packard 5890 gas chromatograph equipped with a flame ionization detector (11). Pool size was determined as the bile acid content of the small intestine, liver, and gallbladder that were removed from non-fasted mice. Total bile acids were extracted in ethanol (9), and analyzed using HPLC as described (12). Individual bile acid species were measured using an evaporative light scatter detector (Alltech ELSD 800). Bile acids were identified and quantified by comparison to known amounts of authentic standards purchased from Steraloids.

Statistical analyses

. Mean values ± SE are shown unless otherwise indicated. The data were evaluated for statistically significant differences using the two-tailed Student's t test or by ANOVA (Tukey-Kramer honestly significant difference) (Statview).

Differences were considered statistically significant at P < 0.05.

1. Dawson PA, et al. (2003) Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 278:33920-33927.

2. Carr TP, Andresen CJ, Rudel LL (1993) Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26:39-42.

3. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153-1163.

4. Yu L, et al. (2002) Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99:16237-16242.

5. Belinsky MG, et al. (2005) Analysis of the in vivo functions of Mrp3. Mol Pharmacol 68:160-168.

6. Dawson PA, et al. (2005) The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 280:6960-6968.

7. Frankenberg T, et al. (2006) Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. Am J Physiol:G912-G922.

8. Saeki T, et al. (1999) Characterization, cDNA cloning, and functional expression of mouse ileal sodium-dependent bile acid transporter. J Biochem (Tokyo) 125:846-851.

9. Schwarz M, Russell DW, Dietschy JM, Turley SD (1998) Marked reduction in bile acid synthesis in cholesterol 7alpha-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J Lipid Res 39:1833-1843.

10. Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M (1981) Direct spectrophotometry of total bile acids in serum. Clin Chem 27:1352-1356.

11. Temel RE, et al. (2005) Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2. J Lipid Res 46:2423-2431.

12. Torchia EC, Labonte ED, Agellon LB (2001) Separation and quantitation of bile acids using an isocratic solvent system for high performance liquid chromatography coupled to an evaporative light scattering detector. Anal Biochem 298:293-298.